Onxeo SA Shares Owned By Institutions vs. Price To Earning

C4X Stock  EUR 0.07  0.0009  1.26%   
Based on the key profitability measurements obtained from Onxeo SA's financial statements, Onxeo SA may not be well positioned to generate adequate gross income at the moment. It has a very high risk of underperforming in January. Profitability indicators assess Onxeo SA's ability to earn profits and add value for shareholders.
For Onxeo SA profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Onxeo SA to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Onxeo SA utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Onxeo SA's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Onxeo SA over time as well as its relative position and ranking within its peers.
  
Check out Trending Equities.
Please note, there is a significant difference between Onxeo SA's value and its price as these two are different measures arrived at by different means. Investors typically determine if Onxeo SA is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Onxeo SA's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Onxeo SA Price To Earning vs. Shares Owned By Institutions Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Onxeo SA's current stock value. Our valuation model uses many indicators to compare Onxeo SA value to that of its competitors to determine the firm's financial worth.
Onxeo SA is number one stock in shares owned by institutions category among its peers. It also is number one stock in price to earning category among its peers reporting about  4.00  of Price To Earning per Shares Owned By Institutions. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Onxeo SA's earnings, one of the primary drivers of an investment's value.

Onxeo Price To Earning vs. Shares Owned By Institutions

Shares Owned by Institutions show the percentage of the outstanding shares of stock issued by a company that is currently owned by other institutions such as asset management firms, hedge funds, or investment banks. Many investors like investing in companies with a large percentage of the firm owned by institutions because they believe that larger firms such as banks, pension funds, and mutual funds, will invest when they think that good things are going to happen.

Onxeo SA

Shares Held by Institutions

 = 

Funds and Banks

+

Firms

 = 
12.72 %
Since Institution investors conduct a lot of independent research they tend to be more involved and usually more knowledgeable about entities they invest as compared to amateur investors.
Price to Earnings ratio is typically used for current valuation of a company and is one of the most popular ratios that investors monitor daily. Holding a low PE stock is less risky because when a company's profitability falls, it is likely that earnings will also go down as well. In other words, if you start from a lower position, your downside risk is limited. There are also some investors who believe that low Price to Earnings ratio reflects the low pricing because a given company is in trouble. On the other hand, a higher PE ratio means that investors are paying more for each unit of profit.

Onxeo SA

P/E

 = 

Market Value Per Share

Earnings Per Share

 = 
50.90 X
Generally speaking, the Price to Earnings ratio gives investors an idea of what the market is willing to pay for the company's current earnings.

Onxeo Price To Earning Comparison

Onxeo SA is currently under evaluation in price to earning category among its peers.

Onxeo SA Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Onxeo SA, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Onxeo SA will eventually generate negative long term returns. The profitability progress is the general direction of Onxeo SA's change in net profit over the period of time. It can combine multiple indicators of Onxeo SA, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Onxeo SA, a clinical-stage biotechnology company, designs and develops oncology drugs for tumor DNA repair functions worldwide. Onxeo SA was incorporated in 1997 and is headquartered in Paris, France. ONXEO S operates under Biotechnology classification in Germany and is traded on Frankfurt Stock Exchange. It employs 29 people.

Onxeo Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Onxeo SA. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Onxeo SA position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Onxeo SA's important profitability drivers and their relationship over time.

Use Onxeo SA in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Onxeo SA position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Onxeo SA will appreciate offsetting losses from the drop in the long position's value.

Onxeo SA Pair Trading

Onxeo SA Pair Trading Analysis

The ability to find closely correlated positions to Onxeo SA could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Onxeo SA when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Onxeo SA - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Onxeo SA to buy it.
The correlation of Onxeo SA is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Onxeo SA moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Onxeo SA moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Onxeo SA can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Onxeo SA position

In addition to having Onxeo SA in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Shipbuilding Railroad Equipment Thematic Idea Now

Shipbuilding Railroad Equipment
Shipbuilding Railroad Equipment Theme
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Shipbuilding Railroad Equipment theme has 16 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Shipbuilding Railroad Equipment Theme or any other thematic opportunities.
View All  Next Launch

Other Information on Investing in Onxeo Stock

To fully project Onxeo SA's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Onxeo SA at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Onxeo SA's income statement, its balance sheet, and the statement of cash flows.
Potential Onxeo SA investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although Onxeo SA investors may work on each financial statement separately, they are all related. The changes in Onxeo SA's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Onxeo SA's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.